المؤلفون: Villaruz, LC, Socinski, MA

المصدر: Clinical Pharmacology & Therapeutics; Sep2016, Vol. 100 Issue 3, p212-214, 3p

مصطلحات موضوعية: NON-small-cell lung carcinoma, IMMUNOTHERAPY, IMMUNOHISTOCHEMISTRY, PEMBROLIZUMAB, LIGANDS (Biochemistry), T cells, PATIENTS

المؤلفون: Luo J; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Villaruz LC; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA. Electronic address: villaruzl@upmc.edu.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Jun 10. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

المؤلفون: Munster P, Iannotti N, Cho DC, Kirkwood JM, Villaruz LC, Gibney GT, Hodi FS, Mettu NB, Jones M, Bowman J, Smith M, Lakshminarayanan M, O'Day S

المصدر: Cancer research communications [Cancer Res Commun] 2024 Mar 13; Vol. 4 (3), pp. 785.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Munster P; Department of Medicine, Division of Hematology/Oncology, UCSF, San Francisco, California., Iannotti N; Hematology-Oncology Associates of Treasure Coast, Port St Lucie, Florida., Cho DC; NYU Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York City, New York City., Kirkwood JM; UPMC Hillman Cancer Center Melanoma and Skin Cancer Program, Pittsburgh, Pennsylvania., Villaruz LC; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Gibney GT; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia., Hodi FS; Dana-Farber Cancer Institute, Boston, Massachusetts., Mettu NB; Duke Cancer Institute, Durham, North Carolina., Jones M; Incyte Corporation, Wilmington, Delaware., Bowman J; Incyte Corporation, Wilmington, Delaware., Smith M; Incyte Corporation, Wilmington, Delaware., Lakshminarayanan M; Incyte Corporation, Wilmington, Delaware., O'Day S; John Wayne Cancer Institute of Providence, Saint John's Health Center, Santa Monica, California.

المصدر: Cancer research communications [Cancer Res Commun] 2023 Dec 19; Vol. 3 (12), pp. 2572-2584.

نوع المنشور: Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Programmed Cell Death 1 Receptor*/therapeutic use , Neoplasms*/drug therapy, Humans ; Diarrhea ; Nausea

المؤلفون: Takahashi N; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland.; National Cancer Center Hospital East, Kashiwa, Japan., Hao Z; Division of Medical Oncology, University of Kentucky College of Medicine, Lexington., Villaruz LC; Division of Hematology/Oncology, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania., Zhang J; Division of Medical Oncology, University of Kansas Medical Center, Kansas City, Kansas., Ruiz J; Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina., Petty WJ; Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina., Mamdani H; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Riess JW; UC Davis Comprehensive Cancer Center, Sacramento, California., Nieva J; Norris Cancer Center, University of Southern California, Los Angeles., Pachecho JM; University of Colorado Cancer Center, Aurora., Fuld AD; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Shum E; Laura and Isaac Perlmutter Cancer Center, New York, New York., Chauhan A; Division of Medical Oncology, University of Kentucky College of Medicine, Lexington., Nichols S; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Shimellis H; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., McGlone J; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Sciuto L; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Pinkiert D; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Graham C; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Shelat M; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Kattappuram R; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Abel M; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Schroeder B; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Upadhyay D; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Krishnamurthy M; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Sharma AK; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Kumar R; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Malin J; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Schultz CW; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Goyal S; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Redon CE; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Pommier Y; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Aladjem MI; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Gore SD; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Steinberg SM; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Vilimas R; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Desai P; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland., Thomas A; National Cancer Institute, Center for Cancer Research, Bethesda, Maryland.

المصدر: JAMA oncology [JAMA Oncol] 2023 Dec 01; Vol. 9 (12), pp. 1669-1677.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Small Cell Lung Carcinoma*/pathology , Lung Neoplasms*/pathology, Humans ; Male ; Middle Aged ; Female ; Topotecan/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Recurrence

المؤلفون: Shaverdashvili K; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Reyes V; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Wang H; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Mehta D; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Marsh C; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Waas JK; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., VanderWeele RA; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Peracha SM; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Liang H; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA., Socinski MA; AdventHealth Cancer Institute, 2501 N. Orange Ave, Suite 689, Orlando, FL, 32804, USA., Gerber DE; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA., Dowell JE; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA., Villaruz LC; UPMC Hillman Cancer Center, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.

المصدر: EClinicalMedicine [EClinicalMedicine] 2023 Nov 21; Vol. 66, pp. 102317. Date of Electronic Publication: 2023 Nov 21 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: Gentzler RD; Division of Hematology/Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Villaruz LC; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA, USA., Rhee JC; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA, USA., Horton B; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA., Mock J; Division of Hematology/Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Hanley M; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA., Kim K; Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Rudek MA; Department of Oncology and Medicine, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Phelps MA; Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Carducci MA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Piekarz R; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Park KS; Department of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Bullock TN; Department of Pathology, University of Virginia Cancer Center, Charlottesville, VA, USA., Rudin CM; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: The oncologist [Oncologist] 2023 Nov 02; Vol. 28 (11), pp. 1007-e1107.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Small Cell Lung Carcinoma*/drug therapy , Lung Neoplasms*/drug therapy , Neutropenia*/chemically induced , Thrombocytopenia*/chemically induced , Anemia*/chemically induced, Humans ; Male ; Female ; Etoposide ; Carboplatin ; Bayes Theorem ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Luke JJ; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Dadey RE; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Augustin RC; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Newman S; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Singh KB; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Doerfler R; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Behr S; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA., Lee P; Pfizer, Inc. Boulder, CO, USA., Isett B; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Cancer Bioinformatics Core, UPMC, Pittsburgh, PA, USA., Deitrick C; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Cancer Bioinformatics Core, UPMC, Pittsburgh, PA, USA., Li A; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA., Joy M; Translational Pathology Imaging Laboratory, UPMC, Pittsburgh, PA, USA., Reeder C; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA., Smith K; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA., Urban J; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA., Sellitto L; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA., Jelinek M; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Biostatistics Core, UPMC, Pittsburgh, PA, USA., Christner SM; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA., Villaruz LC; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Kulkarni A; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA., Davar D; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Poklepovic AS; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA., Najjar Y; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Zandberg DP; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA., Soloff AC; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA., Bruno TC; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA., Vujanović L; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA., Skinner HD; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA., Ferris RL; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA., Bao R; Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

المصدر: Research square [Res Sq] 2023 Aug 19. Date of Electronic Publication: 2023 Aug 19.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE

المؤلفون: Villaruz LC; Division of Hematology/Oncology, Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Blumenschein GR Jr; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Otterson GA; The Ohio State University-James Comprehensive Cancer Center, Columbus, Ohio, USA., Leal TA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.

المصدر: Cancer [Cancer] 2023 May 01; Vol. 129 (9), pp. 1319-1350. Date of Electronic Publication: 2023 Feb 27.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/pathology, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Programmed Cell Death 1 Receptor ; Immunotherapy/adverse effects ; B7-H1 Antigen ; Tumor Microenvironment

المؤلفون: Villaruz LC; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh., Wang X; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham., Bertino EM; Division of Medical Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus., Gu L; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham., Antonia SJ; Duke Cancer Institute, Durham, USA., Burns TF; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh., Clarke J; Duke Cancer Institute, Durham, USA., Crawford J; Duke Cancer Institute, Durham, USA., Evans TL; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh., Friedland DM; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh., Otterson GA; Division of Medical Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus., Ready NE; Duke Cancer Institute, Durham, USA., Wozniak AJ; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh., Stinchcombe TE; Duke Cancer Institute, Durham, USA. Electronic address: Thomas.stinchcombe@duke.edu.

المصدر: ESMO open [ESMO Open] 2023 Apr; Vol. 8 (2), pp. 101183. Date of Electronic Publication: 2023 Mar 09.

نوع المنشور: Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Humans ; Male ; Female ; Aged ; Protein Kinase Inhibitors/adverse effects ; Mutation ; ErbB Receptors/genetics ; Exons/genetics